MARKET

TCBWF

TCBWF

TC BIOPHARM HOLDINGS PLC
OTCPK
0.0025
NaN%
Closed 09:30 12/05 EST
OPEN
--
PREV CLOSE
0.0025
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.023
52 WEEK LOW
0.0011
MARKET CAP
--
P/E (TTM)
-0.0619
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TCBWF last week (1124-1128)?
Weekly Report · 5d ago
Weekly Report: what happened at TCBWF last week (1117-1121)?
Weekly Report · 11/24 09:54
Weekly Report: what happened at TCBWF last week (1110-1114)?
Weekly Report · 11/17 09:54
Weekly Report: what happened at TCBWF last week (1103-1107)?
Weekly Report · 11/10 09:52
Weekly Report: what happened at TCBWF last week (1027-1031)?
Weekly Report · 11/03 09:51
Weekly Report: what happened at TCBWF last week (1020-1024)?
Weekly Report · 10/27 09:54
Weekly Report: what happened at TCBWF last week (1013-1017)?
Weekly Report · 10/20 09:52
Weekly Report: what happened at TCBWF last week (1006-1010)?
Weekly Report · 10/13 09:54
More
About TCBWF
TC BioPharm (Holdings) plc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies (GD-Ts) for the treatment of cancer with human efficacy data in acute myeloid leukemia. The Company is conducting two investigator-initiated clinical trials for its unmodified gamma-delta T cell product line - phase IIb/III pivotal trial in treatment of acute myeloid leukemia using its proprietary allogeneic CryoTC technology to provide frozen product to clinics worldwide. Its lead product is TCB-008. In addition to unmodified allogenic GD-Ts for treatment of blood cancers, the Company is also developing an expanded platform for TCB-008 use case in anti-fungal, anti-viral and anti-microbial diseases. Its unmodified cell therapy, used in the treatment of acute myeloid leukemia, is supplied under the name OmnImmune. It is also developing a range of genetically modified CAR-T products for the treatment of solid cancers.

Webull offers TC Biopharm (Holdings) PLC - ADR stock information, including OTCPK: TCBWF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TCBWF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TCBWF stock methods without spending real money on the virtual paper trading platform.